Logo image of GEHC

GE HEALTHCARE TECHNOLOGY (GEHC) Stock Fundamental Analysis

NASDAQ:GEHC - Nasdaq - US36266G1076 - Common Stock - Currency: USD

74.45  -0.68 (-0.91%)

After market: 74.45 0 (0%)

Fundamental Rating

5

GEHC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. While GEHC has a great profitability rating, there are quite some concerns on its financial health. GEHC scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

GEHC had positive earnings in the past year.
GEHC had a positive operating cash flow in the past year.
In the past 5 years GEHC has always been profitable.
GEHC had a positive operating cash flow in each of the past 5 years.
GEHC Yearly Net Income VS EBIT VS OCF VS FCFGEHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

GEHC has a Return On Assets of 6.50%. This is amongst the best in the industry. GEHC outperforms 87.70% of its industry peers.
GEHC has a Return On Equity of 23.76%. This is amongst the best in the industry. GEHC outperforms 95.72% of its industry peers.
With an excellent Return On Invested Capital value of 8.50%, GEHC belongs to the best of the industry, outperforming 89.30% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for GEHC is in line with the industry average of 7.89%.
The 3 year average ROIC (8.36%) for GEHC is below the current ROIC(8.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.5%
ROE 23.76%
ROIC 8.5%
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
GEHC Yearly ROA, ROE, ROICGEHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

GEHC has a better Profit Margin (11.03%) than 86.10% of its industry peers.
GEHC's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 13.71%, GEHC belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
In the last couple of years the Operating Margin of GEHC has remained more or less at the same level.
GEHC has a Gross Margin of 41.99%. This is in the lower half of the industry: GEHC underperforms 64.71% of its industry peers.
GEHC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.71%
PM (TTM) 11.03%
GM 41.99%
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
GEHC Yearly Profit, Operating, Gross MarginsGEHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GEHC is still creating some value.
GEHC has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, GEHC has an improved debt to assets ratio.
GEHC Yearly Shares OutstandingGEHC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M 400M
GEHC Yearly Total Debt VS Total AssetsGEHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

GEHC has an Altman-Z score of 1.84. This is not the best score and indicates that GEHC is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.84, GEHC perfoms like the industry average, outperforming 58.82% of the companies in the same industry.
GEHC has a debt to FCF ratio of 6.40. This is a slightly negative value and a sign of low solvency as GEHC would need 6.40 years to pay back of all of its debts.
GEHC has a Debt to FCF ratio of 6.40. This is in the better half of the industry: GEHC outperforms 78.61% of its industry peers.
GEHC has a Debt/Equity ratio of 0.74. This is a neutral value indicating GEHC is somewhat dependend on debt financing.
The Debt to Equity ratio of GEHC (0.74) is worse than 71.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 6.4
Altman-Z 1.84
ROIC/WACC1.05
WACC8.08%
GEHC Yearly LT Debt VS Equity VS FCFGEHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

GEHC has a Current Ratio of 0.98. This is a bad value and indicates that GEHC is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of GEHC (0.98) is worse than 90.37% of its industry peers.
GEHC has a Quick Ratio of 0.98. This is a bad value and indicates that GEHC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.76, GEHC is not doing good in the industry: 88.24% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.76
GEHC Yearly Current Assets VS Current LiabilitesGEHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

GEHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.29%, which is quite good.
The Earnings Per Share has been growing slightly by 5.32% on average over the past years.
GEHC shows a small growth in Revenue. In the last year, the Revenue has grown by 1.55%.
The Revenue has been growing slightly by 3.41% on average over the past years.
EPS 1Y (TTM)15.29%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%12.22%
Revenue 1Y (TTM)1.55%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%2.73%

3.2 Future

The Earnings Per Share is expected to grow by 5.34% on average over the next years.
GEHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.52% yearly.
EPS Next Y-7.45%
EPS Next 2Y2.04%
EPS Next 3Y5.76%
EPS Next 5Y5.34%
Revenue Next Year3.01%
Revenue Next 2Y3.85%
Revenue Next 3Y4.13%
Revenue Next 5Y3.52%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
GEHC Yearly Revenue VS EstimatesGEHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B
GEHC Yearly EPS VS EstimatesGEHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

GEHC is valuated correctly with a Price/Earnings ratio of 16.18.
GEHC's Price/Earnings ratio is rather cheap when compared to the industry. GEHC is cheaper than 83.96% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.51. GEHC is valued slightly cheaper when compared to this.
GEHC is valuated correctly with a Price/Forward Earnings ratio of 15.92.
82.89% of the companies in the same industry are more expensive than GEHC, based on the Price/Forward Earnings ratio.
GEHC is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.58, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.18
Fwd PE 15.92
GEHC Price Earnings VS Forward Price EarningsGEHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 84.49% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, GEHC is valued cheaply inside the industry as 85.03% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 24.81
EV/EBITDA 12.32
GEHC Per share dataGEHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

The excellent profitability rating of GEHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.04
EPS Next 2Y2.04%
EPS Next 3Y5.76%

3

5. Dividend

5.1 Amount

GEHC has a yearly dividend return of 0.18%, which is pretty low.
GEHC's Dividend Yield is rather good when compared to the industry average which is at 1.75. GEHC pays more dividend than 90.37% of the companies in the same industry.
With a Dividend Yield of 0.18, GEHC pays less dividend than the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 0.18%

5.2 History

GEHC has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
GEHC Yearly Dividends per shareGEHC Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

GEHC pays out 2.61% of its income as dividend. This is a sustainable payout ratio.
DP2.61%
EPS Next 2Y2.04%
EPS Next 3Y5.76%
GEHC Yearly Income VS Free CF VS DividendGEHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
GEHC Dividend Payout.GEHC Dividend Payout, showing the Payout Ratio.GEHC Dividend Payout.PayoutRetained Earnings

GE HEALTHCARE TECHNOLOGY

NASDAQ:GEHC (7/14/2025, 8:00:01 PM)

After market: 74.45 0 (0%)

74.45

-0.68 (-0.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners80.59%
Inst Owner Change0%
Ins Owners0.28%
Ins Owner Change0.44%
Market Cap34.09B
Analysts80.77
Price Target88.82 (19.3%)
Short Float %1.72%
Short Ratio2.01
Dividend
Industry RankSector Rank
Dividend Yield 0.18%
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP2.61%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-25 2025-04-25 (0.035)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.46%
Min EPS beat(2)8.42%
Max EPS beat(2)12.49%
EPS beat(4)4
Avg EPS beat(4)6.81%
Min EPS beat(4)0.18%
Max EPS beat(4)12.49%
EPS beat(8)7
Avg EPS beat(8)5.57%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.87%
Min Revenue beat(2)-2.17%
Max Revenue beat(2)0.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.61%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-1.79%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.07%
PT rev (3m)-13.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15.96%
EPS NY rev (1m)0.54%
EPS NY rev (3m)-13.16%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)1.34%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)1.32%
Valuation
Industry RankSector Rank
PE 16.18
Fwd PE 15.92
P/S 1.72
P/FCF 24.81
P/OCF 19.13
P/B 3.71
P/tB N/A
EV/EBITDA 12.32
EPS(TTM)4.6
EY6.18%
EPS(NY)4.68
Fwd EY6.28%
FCF(TTM)3
FCFY4.03%
OCF(TTM)3.89
OCFY5.23%
SpS43.24
BVpS20.06
TBVpS-11.85
PEG (NY)N/A
PEG (5Y)3.04
Profitability
Industry RankSector Rank
ROA 6.5%
ROE 23.76%
ROCE 11.49%
ROIC 8.5%
ROICexc 9.49%
ROICexgc 30.64%
OM 13.71%
PM (TTM) 11.03%
GM 41.99%
FCFM 6.94%
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
ROICexc(3y)9.28%
ROICexc(5y)10.16%
ROICexgc(3y)32.48%
ROICexgc(5y)41.69%
ROCE(3y)11.31%
ROCE(5y)12.72%
ROICexcg growth 3Y-14.77%
ROICexcg growth 5YN/A
ROICexc growth 3Y-4.79%
ROICexc growth 5YN/A
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 6.4
Debt/EBITDA 2.07
Cap/Depr 71.83%
Cap/Sales 2.06%
Interest Coverage 4.74
Cash Conversion 54.3%
Profit Quality 62.94%
Current Ratio 0.98
Quick Ratio 0.76
Altman-Z 1.84
F-Score5
WACC8.08%
ROIC/WACC1.05
Cap/Depr(3y)60.52%
Cap/Depr(5y)52.47%
Cap/Sales(3y)1.9%
Cap/Sales(5y)1.73%
Profit Quality(3y)98.54%
Profit Quality(5y)74.63%
High Growth Momentum
Growth
EPS 1Y (TTM)15.29%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%12.22%
EPS Next Y-7.45%
EPS Next 2Y2.04%
EPS Next 3Y5.76%
EPS Next 5Y5.34%
Revenue 1Y (TTM)1.55%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%2.73%
Revenue Next Year3.01%
Revenue Next 2Y3.85%
Revenue Next 3Y4.13%
Revenue Next 5Y3.52%
EBIT growth 1Y12.33%
EBIT growth 3Y-2.07%
EBIT growth 5Y4.33%
EBIT Next Year11.86%
EBIT Next 3Y9.57%
EBIT Next 5Y8.87%
FCF growth 1Y-9.57%
FCF growth 3Y4.48%
FCF growth 5Y0.56%
OCF growth 1Y-7.14%
OCF growth 3Y6.68%
OCF growth 5Y1.2%